Azatioprina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Azatioprina" in Italian language version.

refsWebsite

Global rank Italian rank

74nih.gov

4^th place

9^th place

28doi.org

2^nd place

7^th place

25oadoi.org

799^th place

22^nd place

9archive.org

6^th place

8^th place

1torrinomedica.it

low place

2,002^nd place

1upol.cz

low place

1passonieditore.it

low place

archive.org

BB. Tan, JT. Lear; DJ. Gawkrodger; JS. English, Azathioprine in dermatology: a survey of current practice in the U.K., in Br J Dermatol, vol. 136, n. 3, marzo 1997, pp. 351-5, PMID 9115914.
A. Bérezné, B. Ranque; D. Valeyre; M. Brauner; Y. Allanore; D. Launay; V. Le Guern; JE. Kahn; LJ. Couderc; J. Constans; P. Cohen, Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study., in J Rheumatol, vol. 35, n. 6, giugno 2008, pp. 1064-72, PMID 18464307.
RP. Baughman, U. Costabel; RM. du Bois, Treatment of sarcoidosis., in Clin Chest Med, vol. 29, n. 3, settembre 2008, pp. 533-48, ix-x, DOI:10.1016/j.ccm.2008.03.012, PMID 18539243.
AM. Krensky, C. Clayberger, HLA-derived peptides as novel immunosuppressives., in Nephrol Dial Transplant, vol. 12, n. 5, maggio 1997, pp. 865-8, PMID 9175033.
CJ. Goddard, PJ. August; PJ. Whorwell, Alopecia totalis in a patient with Crohn's disease and its treatment with azathioprine., in Postgrad Med J, vol. 65, n. 761, marzo 1989, pp. 188-9, PMID 2813243.
NE. Rinkardt, SA. Kruth, Azathioprine-induced bone marrow toxicity in four dogs., in Can Vet J, vol. 37, n. 10, ottobre 1996, pp. 612-3, PMID 8896876.
Y. Masunaga, K. Ohno; R. Ogawa; M. Hashiguchi; H. Echizen; H. Ogata, Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease., in Ann Pharmacother, vol. 41, n. 1, gennaio 2007, pp. 21-8, DOI:10.1345/aph.1H219, PMID 17200426.
DB. DeWitte, MK. Buick; SE. Cyran; MJ. Maisels, Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone., in J Pediatr, vol. 105, n. 4, ottobre 1984, pp. 625-8, PMID 6481541.
K. Payne, W. Newman; E. Fargher; K. Tricker; IN. Bruce; WE. Ollier, TPMT testing in rheumatology: any better than routine monitoring?, in Rheumatology (Oxford), vol. 46, n. 5, maggio 2007, pp. 727-9, DOI:10.1093/rheumatology/kel427, PMID 17255139.

doi.org

dx.doi.org

R. Marcén, Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection., in Drugs, vol. 69, n. 16, novembre 2009, pp. 2227-43, DOI:10.2165/11319260-000000000-00000, PMID 19852526.
C. Monchaud, P. Marquet, Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I., in Clin Pharmacokinet, vol. 48, n. 7, 2009, pp. 419-62, DOI:10.2165/11317230-000000000-00000, PMID 19691367.
G. Germani, M. Pleguezuelo; F. Villamil; S. Vaghjiani; E. Tsochatzis; L. Andreana; AK. Burroughs, Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil., in Am J Transplant, vol. 9, n. 8, agosto 2009, pp. 1725-31, DOI:10.1111/j.1600-6143.2009.02705.x, PMID 19538488.
RE. Curtis, C. Metayer; JD. Rizzo; G. Socié; KA. Sobocinski; ME. Flowers; WD. Travis; LB. Travis; MM. Horowitz; HJ. Deeg, Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study., in Blood, vol. 105, n. 10, maggio 2005, pp. 3802-11, DOI:10.1182/blood-2004-09-3411, PMID 15687239.
I. Kaufman, D. Schwartz; D. Caspi; D. Paran, Sjögren's syndrome - not just Sicca: renal involvement in Sjögren's syndrome., in Scand J Rheumatol, vol. 37, n. 3, pp. 213-8, DOI:10.1080/03009740701867323, PMID 18465457.
RK. Hoyles, RW. Ellis; J. Wellsbury; B. Lees; P. Newlands; NS. Goh; C. Roberts; S. Desai; AL. Herrick; NJ. McHugh; NM. Foley, A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma., in Arthritis Rheum, vol. 54, n. 12, dicembre 2006, pp. 3962-70, DOI:10.1002/art.22204, PMID 17133610.
N. Blank, R. Max; HM. Lorenz, The role of DMARDs in systemic sclerosis therapy., in Rheumatology (Oxford), 45 Suppl 3, ottobre 2006, pp. iii42-4, DOI:10.1093/rheumatology/kel289, PMID 16987834.
N. Hunzelmann, P. Moinzadeh; E. Genth; T. Krieg; W. Lehmacher; I. Melchers; M. Meurer; U. Müller-Ladner; TM. Olski; C. Pfeiffer; G. Riemekasten, High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy., in Arthritis Res Ther, vol. 11, n. 2, 2009, pp. R30, DOI:10.1186/ar2634, PMID 19261182.
A. Prasse, J. Müller-Quernheim, [Sarcoidosis], in Internist (Berl), vol. 50, n. 5, maggio 2009, pp. 581-90, DOI:10.1007/s00108-009-2382-2, PMID 19367373.
RP. Baughman, U. Costabel; RM. du Bois, Treatment of sarcoidosis., in Clin Chest Med, vol. 29, n. 3, settembre 2008, pp. 533-48, ix-x, DOI:10.1016/j.ccm.2008.03.012, PMID 18539243.
T. Poonawalla, MI. Colome-Grimmer; B. Kelly, Ulcerative sarcoidosis in the legs with granulomatous vasculitis., in Clin Exp Dermatol, vol. 33, n. 3, maggio 2008, pp. 282-6, DOI:10.1111/j.1365-2230.2007.02643.x, PMID 18201258.
RP. Baughman, EE. Lower, Novel therapies for sarcoidosis., in Semin Respir Crit Care Med, vol. 28, n. 1, febbraio 2007, pp. 128-33, DOI:10.1055/s-2007-970338, PMID 17330197.
G. Chaidemenos, Z. Apalla; T. Koussidou; I. Papagarifallou; D. Ioannides, High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study., in J Eur Acad Dermatol Venereol, giugno 2010, DOI:10.1111/j.1468-3083.2010.03753.x, PMID 20569289.
DF. Mutasim, Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management., in Drugs Aging, vol. 27, n. 1, 2010, pp. 1-19, DOI:10.2165/11318600-000000000-00000, PMID 20030429.
J. Martín De Carpi, V. Varea, [Response to stopping azathioprine in Crohn's patients on combined treatment with infliximab], in An Pediatr (Barc), vol. 70, n. 3, marzo 2009, pp. 271-7, DOI:10.1016/j.anpedi.2008.09.014, PMID 19409244.
GE. Norby, K. Lerang; H. Holdaas; JT. Gran; EH. Strøm; B. Draganov; I. Os; A. Hartmann; IM. Gilboe, [Lupus-nephritis--diagnosis and treatment], in Tidsskr Nor Laegeforen, vol. 130, n. 11, giugno 2010, pp. 1140-4, DOI:10.4045/tidsskr.09.0583, PMID 20531500.
Y. Kawasaki, Mizoribine: a new approach in the treatment of renal disease., in Clin Dev Immunol, vol. 2009, 2009, p. 681482, DOI:10.1155/2009/681482, PMID 20052390.
HI. Fallatah, HO. Akbar; YA. Qari, Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia., in Saudi J Gastroenterol, vol. 16, n. 2, pp. 95-9, DOI:10.4103/1319-3767.61235, PMID 20339178.
JS. Kil, JH. Lee; AR. Han; JY. Kang; HJ. Won; HY. Jung; HM. Lim; GY. Gwak; MS. Choi; KC. Koh; SW. Paik, Long-term treatment outcomes for autoimmune hepatitis in Korea., in J Korean Med Sci, vol. 25, n. 1, gennaio 2010, pp. 54-60, DOI:10.3346/jkms.2010.25.1.54, PMID 20052348.
S. Durán, M. Apte; GS. Alarcón; MC. Marion; JC. Edberg; RP. Kimberly; J. Zhang; CD. Langefeld; LM. Vilá; JD. Reveille, Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort., in Arthritis Rheum, vol. 59, n. 9, settembre 2008, pp. 1332-40, DOI:10.1002/art.24020, PMID 18759263.
G. Riechsteiner, R. Speich; U. Schanz; EW. Russi; W. Weder; A. Boehler, Haemolytic anaemia after lung transplantation: an immune-mediated phenomenon?, in Swiss Med Wkly, vol. 133, n. 9-10, marzo 2003, pp. 143-7, DOI:10.2003/09/smw-10123, PMID 12707841.
E. Prefontaine, JK. Macdonald; LR. Sutherland, Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease., in Cochrane Database Syst Rev, n. 4, 2009, pp. CD000545, DOI:10.1002/14651858.CD000545.pub2, PMID 19821270.
E. Prefontaine, LR. Sutherland; JK. Macdonald; M. Cepoiu, Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease., in Cochrane Database Syst Rev, n. 1, 2009, pp. CD000067, DOI:10.1002/14651858.CD000067.pub2, PMID 19160175.
IK. Hart, S. Sathasivam; T. Sharshar, Immunosuppressive agents for myasthenia gravis., in Cochrane Database Syst Rev, n. 4, 2007, pp. CD005224, DOI:10.1002/14651858.CD005224.pub2, PMID 17943844.
I. Casetta, G. Iuliano; G. Filippini, Azathioprine for multiple sclerosis., in Cochrane Database Syst Rev, n. 4, 2007, pp. CD003982, DOI:10.1002/14651858.CD003982.pub2, PMID 17943809.
Y. Gong, E. Christensen; C. Gluud, Azathioprine for primary biliary cirrhosis., in Cochrane Database Syst Rev, n. 3, 2007, pp. CD006000, DOI:10.1002/14651858.CD006000.pub2, PMID 17636817.
Y. Masunaga, K. Ohno; R. Ogawa; M. Hashiguchi; H. Echizen; H. Ogata, Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease., in Ann Pharmacother, vol. 41, n. 1, gennaio 2007, pp. 21-8, DOI:10.1345/aph.1H219, PMID 17200426.
K. Payne, W. Newman; E. Fargher; K. Tricker; IN. Bruce; WE. Ollier, TPMT testing in rheumatology: any better than routine monitoring?, in Rheumatology (Oxford), vol. 46, n. 5, maggio 2007, pp. 727-9, DOI:10.1093/rheumatology/kel427, PMID 17255139.

nih.gov

ncbi.nlm.nih.gov

E. Tepperman, D. Ramzy; J. Prodger; R. Sheshgiri; M. Badiwala; H. Ross; V. Raoa, Surgical biology for the clinician: vascular effects of immunosuppression., in Can J Surg, vol. 53, n. 1, febbraio 2010, pp. 57-63, PMID 20100415.
R. Marcén, Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection., in Drugs, vol. 69, n. 16, novembre 2009, pp. 2227-43, DOI:10.2165/11319260-000000000-00000, PMID 19852526.
C. Monchaud, P. Marquet, Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I., in Clin Pharmacokinet, vol. 48, n. 7, 2009, pp. 419-62, DOI:10.2165/11317230-000000000-00000, PMID 19691367.
G. Germani, M. Pleguezuelo; F. Villamil; S. Vaghjiani; E. Tsochatzis; L. Andreana; AK. Burroughs, Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil., in Am J Transplant, vol. 9, n. 8, agosto 2009, pp. 1725-31, DOI:10.1111/j.1600-6143.2009.02705.x, PMID 19538488.
KM. Sullivan, RP. Witherspoon; R. Storb; HJ. Deeg; S. Dahlberg; JE. Sanders; FR. Appelbaum; KC. Doney; P. Weiden; C. Anasetti, Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease., in Blood, vol. 72, n. 2, agosto 1988, pp. 555-61, PMID 3042042.
KM. Sullivan, RP. Witherspoon; R. Storb; P. Weiden; N. Flournoy; S. Dahlberg; HJ. Deeg; JE. Sanders; KC. Doney; FR. Appelbaum, Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation., in Blood, vol. 72, n. 2, agosto 1988, pp. 546-54, PMID 3042041.
RE. Curtis, C. Metayer; JD. Rizzo; G. Socié; KA. Sobocinski; ME. Flowers; WD. Travis; LB. Travis; MM. Horowitz; HJ. Deeg, Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study., in Blood, vol. 105, n. 10, maggio 2005, pp. 3802-11, DOI:10.1182/blood-2004-09-3411, PMID 15687239.
AH. Heurkens, ML. Westedt; FC. Breedveld, Prednisone plus azathioprine treatment in patients with rheumatoid arthritis complicated by vasculitis., in Arch Intern Med, vol. 151, n. 11, novembre 1991, pp. 2249-54, PMID 1953230.
Casetta, I.; Iuliano, G.; Filippini, G., Azathioprine for multiple sclerosis, in Journal of Neurology, Neurosurgery & Psychiatry, vol. 80, n. 2, 2009, pp. 131-132, PMID 19151017.
BB. Tan, JT. Lear; DJ. Gawkrodger; JS. English, Azathioprine in dermatology: a survey of current practice in the U.K., in Br J Dermatol, vol. 136, n. 3, marzo 1997, pp. 351-5, PMID 9115914.
H. Yazici, H. Pazarli; CG. Barnes; Y. Tüzün; Y. Ozyazgan; A. Silman; S. Serdaroğlu; V. Oğuz; S. Yurdakul; GE. Lovatt, A controlled trial of azathioprine in Behçet's syndrome., in N Engl J Med, vol. 322, n. 5, febbraio 1990, pp. 281-5, PMID 2404204.
I. Kaufman, D. Schwartz; D. Caspi; D. Paran, Sjögren's syndrome - not just Sicca: renal involvement in Sjögren's syndrome., in Scand J Rheumatol, vol. 37, n. 3, pp. 213-8, DOI:10.1080/03009740701867323, PMID 18465457.
RJ. Hawley, WT. Hendricks, Treatment of Sjögren syndrome myelopathy with azathioprine and steroids., in Arch Neurol, vol. 59, n. 5, maggio 2002, pp. 875; author reply 876, PMID 12020280.
U. Sjögren, H. Thysell; T. Lindholm, Bone marrow morphology in patients in long-term treatment with azathioprine., in Scand J Haematol, vol. 26, n. 3, marzo 1981, pp. 182-6, PMID 6112792.
R. Laraki, D. Chauveau; LH. Noel; O. Hermine, [Membranous glomerulonephritis during primary Gougerot-Sjögren syndrome], in Presse Med, vol. 34, n. 15, settembre 2005, pp. 1069-72, PMID 16334882.
RK. Hoyles, RW. Ellis; J. Wellsbury; B. Lees; P. Newlands; NS. Goh; C. Roberts; S. Desai; AL. Herrick; NJ. McHugh; NM. Foley, A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma., in Arthritis Rheum, vol. 54, n. 12, dicembre 2006, pp. 3962-70, DOI:10.1002/art.22204, PMID 17133610.
N. Blank, R. Max; HM. Lorenz, The role of DMARDs in systemic sclerosis therapy., in Rheumatology (Oxford), 45 Suppl 3, ottobre 2006, pp. iii42-4, DOI:10.1093/rheumatology/kel289, PMID 16987834.
A. Bérezné, B. Ranque; D. Valeyre; M. Brauner; Y. Allanore; D. Launay; V. Le Guern; JE. Kahn; LJ. Couderc; J. Constans; P. Cohen, Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study., in J Rheumatol, vol. 35, n. 6, giugno 2008, pp. 1064-72, PMID 18464307.
N. Hunzelmann, P. Moinzadeh; E. Genth; T. Krieg; W. Lehmacher; I. Melchers; M. Meurer; U. Müller-Ladner; TM. Olski; C. Pfeiffer; G. Riemekasten, High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy., in Arthritis Res Ther, vol. 11, n. 2, 2009, pp. R30, DOI:10.1186/ar2634, PMID 19261182.
A. Prasse, J. Müller-Quernheim, [Sarcoidosis], in Internist (Berl), vol. 50, n. 5, maggio 2009, pp. 581-90, DOI:10.1007/s00108-009-2382-2, PMID 19367373.
H. Nunes, Y. Uzunhan; D. Bonnet; D. Valeyre, [Sarcoidosis treatment], in Rev Prat, vol. 58, n. 10, maggio 2008, pp. 1099-104, PMID 18652410.
RP. Baughman, U. Costabel; RM. du Bois, Treatment of sarcoidosis., in Clin Chest Med, vol. 29, n. 3, settembre 2008, pp. 533-48, ix-x, DOI:10.1016/j.ccm.2008.03.012, PMID 18539243.
T. Poonawalla, MI. Colome-Grimmer; B. Kelly, Ulcerative sarcoidosis in the legs with granulomatous vasculitis., in Clin Exp Dermatol, vol. 33, n. 3, maggio 2008, pp. 282-6, DOI:10.1111/j.1365-2230.2007.02643.x, PMID 18201258.
RP. Baughman, EE. Lower, Novel therapies for sarcoidosis., in Semin Respir Crit Care Med, vol. 28, n. 1, febbraio 2007, pp. 128-33, DOI:10.1055/s-2007-970338, PMID 17330197.
G. Chaidemenos, Z. Apalla; T. Koussidou; I. Papagarifallou; D. Ioannides, High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study., in J Eur Acad Dermatol Venereol, giugno 2010, DOI:10.1111/j.1468-3083.2010.03753.x, PMID 20569289.
DF. Mutasim, Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management., in Drugs Aging, vol. 27, n. 1, 2010, pp. 1-19, DOI:10.2165/11318600-000000000-00000, PMID 20030429.
MD. Mignogna, G. Fortuna; S. Leuci, Oral pemphigus., in Minerva Stomatol, vol. 58, n. 10, ottobre 2009, pp. 501-18, PMID 19893475.
SL. Fernando, AJ. Broadfoot, Treatment options for pemphigus foliaceus., in G Ital Dermatol Venereol, vol. 144, n. 4, agosto 2009, pp. 363-77, PMID 19755942.
JC. Roujeau, S. Ingen-Housz-Oro; C. Leroux; P. Joly, Treatment of bullous pemphigoid and pemphigus. The French experience, 2009 update., in G Ital Dermatol Venereol, vol. 144, n. 4, agosto 2009, pp. 333-8, PMID 19755939.
C. Roeder, PV. Driesch, Psoriatic erythroderma and bullous pemphigoid treated successfully with acitretin and azathioprine., in Eur J Dermatol, vol. 9, n. 7, pp. 537-9, PMID 10523731.
AM. Krensky, C. Clayberger, HLA-derived peptides as novel immunosuppressives., in Nephrol Dial Transplant, vol. 12, n. 5, maggio 1997, pp. 865-8, PMID 9175033.
G. Jones, M. Crotty; P. Brooks, Psoriatic arthritis: a quantitative overview of therapeutic options. The Psoriatic Arthritis Meta-Analysis Study Group., in Br J Rheumatol, vol. 36, n. 1, gennaio 1997, pp. 95-9, PMID 9117186.
Guidelines for management of patients with psoriasis. Workshop of the Research Unit of the Royal College of Physicians of London; Department of Dermatology, University of Glasgow; British Association of Dermatologists., in BMJ, vol. 303, n. 6806, ottobre 1991, pp. 829-35, PMID 1932977.
PL. Lakatos, Z. Czegledi; T. Szamosi; J. Banai; G. David; F. Zsigmond; T. Pandur; Z. Erdelyi; O. Gemela; J. Papp; L. Lakatos, Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease., in World J Gastroenterol, vol. 15, n. 28, luglio 2009, pp. 3504-10, PMID 19630105.
J. Martín De Carpi, V. Varea, [Response to stopping azathioprine in Crohn's patients on combined treatment with infliximab], in An Pediatr (Barc), vol. 70, n. 3, marzo 2009, pp. 271-7, DOI:10.1016/j.anpedi.2008.09.014, PMID 19409244.
AL. Pinto, LA. Chebli; MS. Ribeiro; FH. Pace; JP. Moraes; FJ. do Amaral; PD. Gaburri; AF. Meirelles de Souza; JM. Chebli, Azathioprine therapy in steroid-dependent patients with Crohn disease: results of a 10-year longitudinal follow-up study., in Med Sci Monit, vol. 15, n. 5, maggio 2009, pp. PI19-26, PMID 19396048.
S. Leite, JM. Ribeiro; SC. Lima; S. Barroso; J. Cotter, [Azathioprine in inflammatory bowel disease], in Acta Med Port, vol. 22, n. 1, pp. 33-40, PMID 19341591.
AP. Rozin, T. Hasin; K. Toledano; L. Guralnik; A. Balbir-Gurman, Seronegative polyarthritis as severe systemic disease., in Neth J Med, vol. 68, n. 6, giugno 2010, pp. 236-41, PMID 20558853.
GE. Norby, K. Lerang; H. Holdaas; JT. Gran; EH. Strøm; B. Draganov; I. Os; A. Hartmann; IM. Gilboe, [Lupus-nephritis--diagnosis and treatment], in Tidsskr Nor Laegeforen, vol. 130, n. 11, giugno 2010, pp. 1140-4, DOI:10.4045/tidsskr.09.0583, PMID 20531500.
C. Ponticelli, RJ. Glassock; G. Moroni, Induction and maintenance therapy in proliferative lupus nephritis., in J Nephrol, vol. 23, n. 1, pp. 9-16, PMID 20091481.
Y. Kawasaki, Mizoribine: a new approach in the treatment of renal disease., in Clin Dev Immunol, vol. 2009, 2009, p. 681482, DOI:10.1155/2009/681482, PMID 20052390.
NE. van der Laan-Baalbergen, SA. Mollema; H. Kritikos; A. Schoe; TW. Huizinga; JJ. Bax; DT. Boumpas; JM. van Laar, Heart failure as presenting manifestation of cardiac involvement in systemic lupus erythematosus., in Neth J Med, vol. 67, n. 9, ottobre 2009, pp. 295-301, PMID 19841486.
HI. Fallatah, HO. Akbar; YA. Qari, Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia., in Saudi J Gastroenterol, vol. 16, n. 2, pp. 95-9, DOI:10.4103/1319-3767.61235, PMID 20339178.
AJ. Czaja, Difficult treatment decisions in autoimmune hepatitis., in World J Gastroenterol, vol. 16, n. 8, febbraio 2010, pp. 934-47, PMID 20180231.
JS. Kil, JH. Lee; AR. Han; JY. Kang; HJ. Won; HY. Jung; HM. Lim; GY. Gwak; MS. Choi; KC. Koh; SW. Paik, Long-term treatment outcomes for autoimmune hepatitis in Korea., in J Korean Med Sci, vol. 25, n. 1, gennaio 2010, pp. 54-60, DOI:10.3346/jkms.2010.25.1.54, PMID 20052348.
MH. Bluth, S. Kohlhoff; KB. Norowitz; JI. Silverberg; S. Chice; M. Nowakowski; HG. Durkin; TA. Smith-Norowitz, Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case report., in Int J Med Sci, vol. 6, n. 4, 2009, pp. 177-83, PMID 19584951.
P. Dite et al., Autoimmune pancreatitis., in Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 158(1), feb 2014, pp. 17-22, PMID 24572485.
CJ. Goddard, PJ. August; PJ. Whorwell, Alopecia totalis in a patient with Crohn's disease and its treatment with azathioprine., in Postgrad Med J, vol. 65, n. 761, marzo 1989, pp. 188-9, PMID 2813243.
S. Durán, M. Apte; GS. Alarcón; MC. Marion; JC. Edberg; RP. Kimberly; J. Zhang; CD. Langefeld; LM. Vilá; JD. Reveille, Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort., in Arthritis Rheum, vol. 59, n. 9, settembre 2008, pp. 1332-40, DOI:10.1002/art.24020, PMID 18759263.
G. Riechsteiner, R. Speich; U. Schanz; EW. Russi; W. Weder; A. Boehler, Haemolytic anaemia after lung transplantation: an immune-mediated phenomenon?, in Swiss Med Wkly, vol. 133, n. 9-10, marzo 2003, pp. 143-7, DOI:10.2003/09/smw-10123, PMID 12707841.
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.9.1. Haematological complications. Anaemia., in Nephrol Dial Transplant, 17 Suppl 4, 2002, pp. 48-9, PMID 12091647.
NE. Rinkardt, SA. Kruth, Azathioprine-induced bone marrow toxicity in four dogs., in Can Vet J, vol. 37, n. 10, ottobre 1996, pp. 612-3, PMID 8896876.
SK. Vesely, JJ. Perdue; MA. Rizvi; DR. Terrell; JN. George, Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review., in Ann Intern Med, vol. 140, n. 2, gennaio 2004, pp. 112-20, PMID 14734334.
DS. Allan, MJ. Kovacs; WF. Clark, Frequently relapsing thrombotic thrombocytopenic purpura treated with cytotoxic immunosuppressive therapy., in Haematologica, vol. 86, n. 8, agosto 2001, pp. 844-50, PMID 11522541.
P. Berchtold, R. McMillan, Therapy of chronic idiopathic thrombocytopenic purpura in adults., in Blood, vol. 74, n. 7, novembre 1989, pp. 2309-17, PMID 2478227.
I. Naitoh, T. Nakazawa; H. Ohara; H. Sano; T. Ando; K. Hayashi; H. Tanaka; F. Okumura; K. Miyabe; M. Yoshida; S. Takahashi, Autoimmune pancreatitis associated with various extrapancreatic lesions during a long-term clinical course successfully treated with azathioprine and corticosteroid maintenance therapy., in Intern Med, vol. 48, n. 23, 2009, pp. 2003-7, PMID 19952482.
T. Itoh, K. Nibe; A. Kojimoto; M. Mikawa; K. Mikawa; K. Uchida; H. Shii, Erythema multiforme possibly triggered by food substances in a dog., in J Vet Med Sci, vol. 68, n. 8, agosto 2006, pp. 869-71, PMID 16953090.
P. Sen, SH. Chua, A case of recurrent erythema multiforme and its therapeutic complications., in Ann Acad Med Singapore, vol. 33, n. 6, novembre 2004, pp. 793-6, PMID 15608841.
G. Roustan, C. Salas; C. Barbadillo; E. Sánchez Yus; J. Mulero; A. Simón, Lupus erythematosus with an erythema multiforme-like eruption., in Eur J Dermatol, vol. 10, n. 6, agosto 2000, pp. 459-62, PMID 10980468.
V. Fonseca e C. W. Havard, Long term treatment of myasthenia gravis with azathioprine., in Postgraduate Medical Journal, vol. 66, n. 772, March 1990, pp. 102–105. URL consultato il 31 ottobre 2017.
DH. Lawson, GE. Lovatt; CS. Gurton; RC. Hennings, Adverse effects of azathioprine., in Adverse Drug React Acute Poisoning Rev, vol. 3, n. 3, 1984, pp. 161-71, PMID 6397980.
E. Prefontaine, JK. Macdonald; LR. Sutherland, Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease., in Cochrane Database Syst Rev, n. 4, 2009, pp. CD000545, DOI:10.1002/14651858.CD000545.pub2, PMID 19821270.
E. Prefontaine, LR. Sutherland; JK. Macdonald; M. Cepoiu, Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease., in Cochrane Database Syst Rev, n. 1, 2009, pp. CD000067, DOI:10.1002/14651858.CD000067.pub2, PMID 19160175.
IK. Hart, S. Sathasivam; T. Sharshar, Immunosuppressive agents for myasthenia gravis., in Cochrane Database Syst Rev, n. 4, 2007, pp. CD005224, DOI:10.1002/14651858.CD005224.pub2, PMID 17943844.
I. Casetta, G. Iuliano; G. Filippini, Azathioprine for multiple sclerosis., in Cochrane Database Syst Rev, n. 4, 2007, pp. CD003982, DOI:10.1002/14651858.CD003982.pub2, PMID 17943809.
Y. Gong, E. Christensen; C. Gluud, Azathioprine for primary biliary cirrhosis., in Cochrane Database Syst Rev, n. 3, 2007, pp. CD006000, DOI:10.1002/14651858.CD006000.pub2, PMID 17636817.
Y. Masunaga, K. Ohno; R. Ogawa; M. Hashiguchi; H. Echizen; H. Ogata, Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease., in Ann Pharmacother, vol. 41, n. 1, gennaio 2007, pp. 21-8, DOI:10.1345/aph.1H219, PMID 17200426.
VK. Gombar, K. Enslein; BW. Blake; K. Einstein, Carcinogenicity of azathioprine: an S-AR investigation., in Mutat Res, vol. 302, n. 1, maggio 1993, pp. 7-12, PMID 7683109.
A. Anstey, L. Lennard; SC. Mayou; JD. Kirby, Pancytopenia related to azathioprine--an enzyme deficiency caused by a common genetic polymorphism: a review., in J R Soc Med, vol. 85, n. 12, dicembre 1992, pp. 752-6, PMID 1494166.
S. Saarikoski, M. Seppälä, Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus., in Am J Obstet Gynecol, vol. 115, n. 8, aprile 1973, pp. 1100-6, PMID 4348000.
DB. DeWitte, MK. Buick; SE. Cyran; MJ. Maisels, Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone., in J Pediatr, vol. 105, n. 4, ottobre 1984, pp. 625-8, PMID 6481541.
AJ. Black, HL. McLeod; HA. Capell; RH. Powrie; LK. Matowe; SC. Pritchard; ES. Collie-Duguid; DM. Reid, Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine., in Ann Intern Med, vol. 129, n. 9, novembre 1998, pp. 716-8, PMID 9841604.
K. Payne, W. Newman; E. Fargher; K. Tricker; IN. Bruce; WE. Ollier, TPMT testing in rheumatology: any better than routine monitoring?, in Rheumatology (Oxford), vol. 46, n. 5, maggio 2007, pp. 727-9, DOI:10.1093/rheumatology/kel427, PMID 17255139.

dailymed.nlm.nih.gov

Azathioprine sodium injection, powder, lyophilized, for solution [Bedford Laboratories], su dailymed.nlm.nih.gov. URL consultato il 1º giugno 2013.

oadoi.org

R. Marcén, Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection., in Drugs, vol. 69, n. 16, novembre 2009, pp. 2227-43, DOI:10.2165/11319260-000000000-00000, PMID 19852526.
C. Monchaud, P. Marquet, Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I., in Clin Pharmacokinet, vol. 48, n. 7, 2009, pp. 419-62, DOI:10.2165/11317230-000000000-00000, PMID 19691367.
G. Germani, M. Pleguezuelo; F. Villamil; S. Vaghjiani; E. Tsochatzis; L. Andreana; AK. Burroughs, Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil., in Am J Transplant, vol. 9, n. 8, agosto 2009, pp. 1725-31, DOI:10.1111/j.1600-6143.2009.02705.x, PMID 19538488.
RE. Curtis, C. Metayer; JD. Rizzo; G. Socié; KA. Sobocinski; ME. Flowers; WD. Travis; LB. Travis; MM. Horowitz; HJ. Deeg, Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study., in Blood, vol. 105, n. 10, maggio 2005, pp. 3802-11, DOI:10.1182/blood-2004-09-3411, PMID 15687239.
I. Kaufman, D. Schwartz; D. Caspi; D. Paran, Sjögren's syndrome - not just Sicca: renal involvement in Sjögren's syndrome., in Scand J Rheumatol, vol. 37, n. 3, pp. 213-8, DOI:10.1080/03009740701867323, PMID 18465457.
RK. Hoyles, RW. Ellis; J. Wellsbury; B. Lees; P. Newlands; NS. Goh; C. Roberts; S. Desai; AL. Herrick; NJ. McHugh; NM. Foley, A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma., in Arthritis Rheum, vol. 54, n. 12, dicembre 2006, pp. 3962-70, DOI:10.1002/art.22204, PMID 17133610.
N. Blank, R. Max; HM. Lorenz, The role of DMARDs in systemic sclerosis therapy., in Rheumatology (Oxford), 45 Suppl 3, ottobre 2006, pp. iii42-4, DOI:10.1093/rheumatology/kel289, PMID 16987834.
N. Hunzelmann, P. Moinzadeh; E. Genth; T. Krieg; W. Lehmacher; I. Melchers; M. Meurer; U. Müller-Ladner; TM. Olski; C. Pfeiffer; G. Riemekasten, High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy., in Arthritis Res Ther, vol. 11, n. 2, 2009, pp. R30, DOI:10.1186/ar2634, PMID 19261182.
A. Prasse, J. Müller-Quernheim, [Sarcoidosis], in Internist (Berl), vol. 50, n. 5, maggio 2009, pp. 581-90, DOI:10.1007/s00108-009-2382-2, PMID 19367373.
T. Poonawalla, MI. Colome-Grimmer; B. Kelly, Ulcerative sarcoidosis in the legs with granulomatous vasculitis., in Clin Exp Dermatol, vol. 33, n. 3, maggio 2008, pp. 282-6, DOI:10.1111/j.1365-2230.2007.02643.x, PMID 18201258.
RP. Baughman, EE. Lower, Novel therapies for sarcoidosis., in Semin Respir Crit Care Med, vol. 28, n. 1, febbraio 2007, pp. 128-33, DOI:10.1055/s-2007-970338, PMID 17330197.
G. Chaidemenos, Z. Apalla; T. Koussidou; I. Papagarifallou; D. Ioannides, High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study., in J Eur Acad Dermatol Venereol, giugno 2010, DOI:10.1111/j.1468-3083.2010.03753.x, PMID 20569289.
DF. Mutasim, Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management., in Drugs Aging, vol. 27, n. 1, 2010, pp. 1-19, DOI:10.2165/11318600-000000000-00000, PMID 20030429.
J. Martín De Carpi, V. Varea, [Response to stopping azathioprine in Crohn's patients on combined treatment with infliximab], in An Pediatr (Barc), vol. 70, n. 3, marzo 2009, pp. 271-7, DOI:10.1016/j.anpedi.2008.09.014, PMID 19409244.
GE. Norby, K. Lerang; H. Holdaas; JT. Gran; EH. Strøm; B. Draganov; I. Os; A. Hartmann; IM. Gilboe, [Lupus-nephritis--diagnosis and treatment], in Tidsskr Nor Laegeforen, vol. 130, n. 11, giugno 2010, pp. 1140-4, DOI:10.4045/tidsskr.09.0583, PMID 20531500.
Y. Kawasaki, Mizoribine: a new approach in the treatment of renal disease., in Clin Dev Immunol, vol. 2009, 2009, p. 681482, DOI:10.1155/2009/681482, PMID 20052390.
HI. Fallatah, HO. Akbar; YA. Qari, Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia., in Saudi J Gastroenterol, vol. 16, n. 2, pp. 95-9, DOI:10.4103/1319-3767.61235, PMID 20339178.
JS. Kil, JH. Lee; AR. Han; JY. Kang; HJ. Won; HY. Jung; HM. Lim; GY. Gwak; MS. Choi; KC. Koh; SW. Paik, Long-term treatment outcomes for autoimmune hepatitis in Korea., in J Korean Med Sci, vol. 25, n. 1, gennaio 2010, pp. 54-60, DOI:10.3346/jkms.2010.25.1.54, PMID 20052348.
S. Durán, M. Apte; GS. Alarcón; MC. Marion; JC. Edberg; RP. Kimberly; J. Zhang; CD. Langefeld; LM. Vilá; JD. Reveille, Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort., in Arthritis Rheum, vol. 59, n. 9, settembre 2008, pp. 1332-40, DOI:10.1002/art.24020, PMID 18759263.
G. Riechsteiner, R. Speich; U. Schanz; EW. Russi; W. Weder; A. Boehler, Haemolytic anaemia after lung transplantation: an immune-mediated phenomenon?, in Swiss Med Wkly, vol. 133, n. 9-10, marzo 2003, pp. 143-7, DOI:10.2003/09/smw-10123, PMID 12707841.
E. Prefontaine, JK. Macdonald; LR. Sutherland, Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease., in Cochrane Database Syst Rev, n. 4, 2009, pp. CD000545, DOI:10.1002/14651858.CD000545.pub2, PMID 19821270.
E. Prefontaine, LR. Sutherland; JK. Macdonald; M. Cepoiu, Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease., in Cochrane Database Syst Rev, n. 1, 2009, pp. CD000067, DOI:10.1002/14651858.CD000067.pub2, PMID 19160175.
IK. Hart, S. Sathasivam; T. Sharshar, Immunosuppressive agents for myasthenia gravis., in Cochrane Database Syst Rev, n. 4, 2007, pp. CD005224, DOI:10.1002/14651858.CD005224.pub2, PMID 17943844.
I. Casetta, G. Iuliano; G. Filippini, Azathioprine for multiple sclerosis., in Cochrane Database Syst Rev, n. 4, 2007, pp. CD003982, DOI:10.1002/14651858.CD003982.pub2, PMID 17943809.
Y. Gong, E. Christensen; C. Gluud, Azathioprine for primary biliary cirrhosis., in Cochrane Database Syst Rev, n. 3, 2007, pp. CD006000, DOI:10.1002/14651858.CD006000.pub2, PMID 17636817.

passonieditore.it

Francesco Del Zotti, Ottimizzazione della terapia con azatioprina. (PDF), in M.D. Medicinae Doctor, vol. 19, n. 1, gennaio 2012, pp. 46-47.

torrinomedica.it

Azatioprina wellcome, su torrinomedica.it. URL consultato il 6 luglio 2010.

upol.cz

biomed.papers.upol.cz

P. Dite et al., Autoimmune pancreatitis., in Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 158(1), feb 2014, pp. 17-22, PMID 24572485.